Nikang Therapeutics

Wilmington, United States · Founded 2017 · $260.0M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$260.0M
Last Round
$200.0M Series CMay 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

NiKang Therapeutics is a clinical-stage biotechnology company established in 2017 to discover and develop innovative small-molecule medicines for cancer. The company advances oncology programs against difficult-to-drug targets through drug discovery and clinical development. Its public materials describe work on small-molecule therapies for cancers including renal cell carcinoma and hepatocellular carcinoma.

Summary

Nikang Therapeutics is a Biotech company based in Wilmington, United States, founded in 2017. It has raised $260.0M in total across 3 rounds, most recently a $200.0M Series C round in May 2021. Investors include RTW Investments, Cormorant Asset Management and EcoR1 Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMay 2021
$200.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nikang Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nikang-therapeutics"><img src="https://indexed.vc/api/badge/company/nikang-therapeutics" alt="Nikang Therapeutics on Indexed.vc" width="260" height="76" /></a>